Acrivon Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Acrivon Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ACRV | Acrivon Therapeutics | -$0.52 | -$0.58 | — | — | $0.00 | — | — | — | 08/12/2025 | Get Alert |
ACRV | Acrivon Therapeutics | -$0.73 | -$0.64 | -$0.51 | 20.31% | $0.00 | — | $0.00 | — | 05/14/2025 | Get Alert |
ACRV | Acrivon Therapeutics | -$0.86 | -$0.65 | -$0.60 | 7.69% | $0.00 | — | $0.00 | — | 03/27/2025 | Get Alert |
ACRV | Acrivon Therapeutics | -$0.66 | -$0.58 | -$0.59 | -1.72% | $0.00 | — | $0.00 | — | 11/13/2024 | Get Alert |
ACRV | Acrivon Therapeutics | -$0.63 | -$0.60 | -$0.52 | 13.33% | $0.00 | — | $0.00 | — | 08/13/2024 | Get Alert |
ACRV | Acrivon Therapeutics | -$0.58 | -$0.84 | -$0.73 | 13.10% | $0.00 | — | $0.00 | — | 05/14/2024 | Get Alert |
ACRV | Acrivon Therapeutics | -$0.80 | -$0.73 | -$0.86 | -17.81% | $0.00 | — | $0.00 | — | 03/28/2024 | Get Alert |
ACRV | Acrivon Therapeutics | -$5.17 | -$0.71 | -$0.66 | 7.04% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
ACRV | Acrivon Therapeutics | -$3.29 | -$0.65 | -$0.63 | 3.08% | — | — | $0.00 | — | 08/11/2023 | Get Alert |
ACRV | Acrivon Therapeutics | -$4.08 | -$0.60 | -$0.58 | 3.33% | — | — | $0.00 | — | 05/09/2023 | Get Alert |
ACRV | Acrivon Therapeutics | -$2.45 | -$1.09 | -$0.80 | 26.61% | $0.00 | — | $0.00 | — | 03/28/2023 | Get Alert |
ACRV | Acrivon Therapeutics | -$1.38 | — | -$5.17 | — | $0.00 | — | $0.00 | — | 12/15/2022 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q1 | 2025-05-14 | $-0.51 | $-0.64 | 20.3 % |
Q4 | 2025-03-27 | $-0.60 | $-0.65 | 7.69 % |
Q3 | 2024-11-13 | $-0.59 | $-0.58 | -1.72 % |
Q2 | 2024-08-13 | $-0.52 | $-0.60 | 13.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Acrivon Therapeutics (ACRV) is scheduled to report earnings on August 12, 2025. The last reported earnings were for reported on May 14, 2025 for Q1.
The Actual EPS was $-0.51, which beat the estimate of $-0.64.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.